Hemodiafiltration for vancomycin overdose in a neonate with end-stage renal failure

Goebel, J.; Ananth, M.; Lewy, J. E.
April 1999
Pediatric Nephrology;1999, Vol. 13, p423
Academic Journal
We describe continuous venovenous hemodiafiltration (CVVHD) with a high-flux membrane as a novel treatment modality for vancomycin overdose associated with renal insufficiency. CVVHD was used in a 6-day-old male with a solitary hypodysplastic kidney, suspected sepsis, and anuric renal failure who subsequently received an accidental tenfold overdose of vancomycin. We furthermore present evidence for the importance of countercurrent dialysis in addition to continuous hemofiltration for optimal vancomycin removal.


Related Articles

  • Graft survival rate in pediatric renal transplantation: A single center experience. Almasi-Hashiani, Amir; Rajaeefard, Abdolreza; Hassanzade, Jafar; Salahi, Heshmatollah; Mehrabani, Davood; Khedmati, Esmaeil // Pakistan Journal of Medical Sciences;Oct-Dec2012, Vol. 28 Issue 5, p806 

    Objective: Renal transplantation is the best option for treatment of the end-stage renal diseases and has more advantages than dialysis. The objective of this study was to determine the ten-year graft survival rate of renal transplantation and its contributing factors among a group of Iranian...

  • Fresenius Medical Care Offers Five Tips to Help Slow the Progression of Kidney Disease.  // Biomedical Market Newsletter;3/7/2012, Vol. 21, p1 

    The article offers information on the tips presented by Fresenius Medical Care North America to slow the progression of chronic kidney disease (CKD). It mentions the five tips which include maintaining body weight, healthy diet and screening for patients with cardiovascular disease. It further...

  • 386. Treatment for more than 1 year resulted in no demonstrable benefit of growth hormone in children with renal failure. Vimalachandra, D.; Craig, J.C.; Cowell, C.T. // Kidney;May/Jun2002, Vol. 11 Issue 3, p128 

    Provides information on a study which examined growth hormone treatment in children with chronic renal failure. Methodology; Results; Conclusion.

  • Reversible diabetes mellitus during growth hormone therapy in chronic renal failure. Filler, Guido; Franke, Doris; Amendt, Peter; Ehrich, Jochen H. H. // Pediatric Nephrology;1998, Vol. 12 Issue 5, p405 

    A 12-year-old girl with short stature due to idiopathic Fanconi syndrome and chronic renal failure was treated with recombinant human growth hormone (rhGH). There was no family history of diabetes mellitus and the glucose tolerance before treatment was normal. Intravenous glucose tolerance tests...

  • Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Edmondson, Stephanie R.; Baker, Naomi L.; Oh, Jun; Kovacs, Gabor; Werther, George A.; Mehls, Otto // Kidney International;Jul2000, Vol. 58 Issue 1, p62 

    Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Background. Children with chronic renal failure (CRF) exhibit growth retardation and a disturbed growth hormone/insulin-like growth factor-I (GH/IGF-I) axis. Treatment of children with CRF with GH or...

  • Effect of enteral feeding on lipid subfractions in children with chronic renal failure. Kari, Jameela A.; Shaw, Vanessa; Vallance, David T.; Rees, Lesley // Pediatric Nephrology;1998, Vol. 12 Issue 5, p401 

    The anorexia of chronic renal failure (CRF) is frequently managed with enteral feeds using combinations of commercial preparations, glucose polymers and fat emulsions. Such feeds might predispose to atherogenic blood lipid profiles. Our aim, therefore, was to compare the blood lipid profiles of...

  • One-year routine renal transplant biopsies in children. Benamenyo, J. P.; Droz, D.; Niaudet, P. // Pediatric Nephrology;Dec2001, Vol. 16 Issue 12, p971 

    In our institution, systematic renal graft biopsies are performed 1 year after transplantation before deciding to switch to alternate-day steroid therapy, which has been shown to be beneficial for statural growth. We analyzed the results of systematic graft biopsies in 145 children with a...

  • Children of non-Western origin with end-stage renal disease in the Netherlands, Belgium and a part of Germany have impaired health-related quality of life compared with Western children. Schoenmaker, Nikki J.; Haverman, Lotte; Tromp, Wilma F.; van der Lee, Johanna H.; Offringa, Martin; Adams, Brigitte; Bouts, Antonia H. M.; Collard, Laure; Cransberg, Karlien; van Dyck, Maria; Godefroid, Nathalie; van Hoeck, Koenraad; Koster-Kamphuis, Linda; Lilien, Marc R.; Raes, Ann; Taylan, Christina; Grootenhuis, Martha A.; Groothoff, Jaap W. // Nephrology Dialysis Transplantation;Feb2014, Vol. 29 Issue 2, p448 

    Background Many children with end-stage renal disease (ESRD) living in Western Europe are of non-Western European origin. They have unfavourable somatic outcomes compared with ESRD children of Western origin. In this study, we compared the Health-related Quality of Life (HRQoL) of both groups....

  • Childhood course of renal insufficiency in a family with a uromodulin gene mutation. Schäffer, Péter; Gombos, Éva; Meichelbeck, Krisztina; Kiss, András; Hart, P.; Bleyer, Anthony // Pediatric Nephrology;Jul2010, Vol. 25 Issue 7, p1355 

    Mutations in the UMOD gene encoding uromodulin (Tamm-Horsfall glycoprotein) result in the autosomal dominant transmission of progressive renal insufficiency and hypo-uricosuric hyperuricemia leading to gout at an early age. The clinical appearance is characterized by renal insufficiency and gout...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics